Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
April 5, 2011
Patent Application Number
11510496
Date Filed
August 25, 2006
Patent Citations Received
Patent Primary Examiner
Patent abstract
A therapeutic and/or cosmetic formulation comprising at least one anti-sense polynucleotide to a connexin protein together with a pharmaceutically acceptable carrier or vehicle is useful in site specific down regulation of connexin protein expression, particularly in reduction of neuronal cells death, wound healing, reduction of inflammation, decrease of scar formation and skin rejuvenation and thickening.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
